1887

Chapter 5 : Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Ebook: Choose a downloadable PDF or ePub file. Chapter is a downloadable PDF file. File must be downloaded within 48 hours of purchase

Buy this Chapter
Digital (?) $15.00

Preview this chapter:
Zoom in
Zoomout

Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815561/9781555814366_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555815561/9781555814366_Chap05-2.gif

Abstract:

This chapter opens with a brief overview of the toll-like receptor (TLR)-dependent and -independent pathways of activation. It then focuses on the activation of transcription factors interferon regulatory factors (IRFs) IRF3 and IRF7 by the atypical IκB kinases (IKKs), TANK-binding kinase 1 (TBK1), and IKK-ε and their role in the induction of type I interferons (IFNs). The majority of IRFs are involved in distinct aspects of the antiviral response, while two members—IRF4 and IRF8—function mainly as regulators of hematopoiesis in concert with the Ets transcription factor. Importantly, expression of the IKK-related kinases is essential to initiate IRF signaling in response to de novo Sendai virus (SeV), vesicular stomatitis virus (VSV), or measles virus infection, and treatment with RNA interference directed against either IKK-ε or TBK1 reduces VSV-inducible IRF3 phosphorylation and IRF-dependent gene expression in human cells. Inhibition of Hsp90 expression by small interfering RNA (siRNA) resulted in an impaired activation of IRF3 following SeV infection. This study proposes that Hsp90 participates in the formation of a complex containing TBK1 and IRF3. In addition to linking TBK1 to the exocyst pathway and Ras-induced transformation, the study demonstrated that the host defense response requires the RalB/Sec5/TBK1 complex following double-stranded RNA (dsRNA) treatment or SeV infection.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5

Key Concept Ranking

Small Interfering RNA
0.5014133
Japanese encephalitis virus
0.4951103
Hepatitis C virus
0.4951103
Japanese encephalitis virus
0.4951103
0.5014133
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Image of Figure 1
Figure 1

TLR-dependent and -independent sensing of viral infection leads to TBK1/IKK-ε activation. Simplified schematic representation of TLR3, 4, 7/8, and 9 and RIG-I/MDA-5 signaling pathways, leading to TBK1 and IKK-ε activation.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Schematic representation of IRF7 and IRF5. Schematic diagram of the principal domains of IRF7 (A) and IRF5 (B). The signal response domain is amplified and important amino acids are shown as gray letters with their respective position number. Pro, proline-rich region; PEST, proline-glutamic acid-serine-threonine domain; CAD, constitutive activation domain; VAD, virus-activated domain; P, phosphorylation site.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Schematic representation of the classical and nonclassical IKK kinases. Shown are schematic diagrams of the principal known domains of IKK-α, IKK-β, TBK1, and IKK-ε. The phosphorylated and ubiquitinated residues are indicated. Sequence homologies of each kinase compared with either IKK-α or IKK-ε are shown as percentages to the right of the schematic. KD, kinase domain; LZ, leucine zipper motif; HLH, helix-loop-helix domain; P, phosphorylation site; Ub, ubiquitination site.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4
Figure 4

Adaptor molecules of the IFN signaling pathway. Schematic representation of SINT-BAD, NAP1, TANK, and NEMO adaptor molecules. CC, coiled-coil domain; Pro, proline-rich domain; ZnF, zinc-finger domain; NEMO ID, NEMO interaction domain; TRAF ID, TRAF interaction domain; TANK ID, TANK interaction domain; LZ, leucine zipper motif.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 5
Figure 5

Negative regulators of the IFN signaling pathway. Schematic representation of A20, SIKE, and DUBA, negative regulators of the IFN pathway. UIM, ubiquitin interacting motif.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 6
Figure 6

Global overview of the regulation of the RIG-I pathway. Schematic representation of signaling complexes formed after activation of the RIG-I pathway following viral infection. Binding of dsRNA by RIG-I leads to dimerization and exposure of CARD domains, allowing interaction with the CARD domain of MAVS. (Left) The mitochondria adaptor MAVS activates the kinases TBK1/IKK-ε through recruitment of TANK and TRAF3. (Right) The adaptors NAP1 and SINTBAD may form similar complexes with MAVS, the kinases, and TRAF3. Recruitment of TRAF6/2 to MAVS leads to NF-κB activation via RIP-1 and NEMO. Only IKK-ε is recruited directly to the mitochondria. TANK (or NAP1) may dissociate from MAVS and form a large cytoplasmic multimeric complex composed of the classical IKK kinases, NEMO, TBK1/IKK-ε, TRAF3, and RIP-1 (complex I), capable of activating both NF-κB and IRF3/7. K63 linked ubiquitination is shown as arrows with oval dots. Phosphorylation is shown as arrows with round dots. Negative regulators (A20, DUBA, and SIKE) are also shown.

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815561.ch05
1. Agashe, V. R., and, F. U. Hartl. 2000. Roles of molecular chaperones in cytoplasmic protein folding. Semin. Cell Dev. Biol. 11:1525.
2. Akira, S. 2006. TLR signaling. Curr. Top. Microbiol. Immunol. 311:116.
3. Andrejeva, J.,, K. S. Childs,, D. F. Young,, T. S. Carlos,, N. Stock,, S. Goodbourn, and, R. E. Randall. 2004. The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter. Proc. Natl. Acad. Sci. USA 101:1726417269.
4. Au, W. C.,, P. A. Moore,, D. W. LaFleur,, B. Tombal, and, P. M. Pitha. 1998. Characterization of the interferon regulatory factor-7 and its potential role in the transcription activation of interferon A genes. J. Biol. Chem. 273:2921029217.
5. Au, W. C.,, P. A. Moore,, W. Lowther,, Y. T. Juang, and, P. M. Pitha. 1995. Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proc. Natl. Acad. Sci. USA 92:1165711661.
6. Aupperle, K. R.,, Y. Yamanishi,, B. L. Bennett,, F. Mercurio,, D. L. Boyle, and, G. S. Firestein. 2001. Expression and regulation of inducible IkappaB kinase (IKK-i) in human fibroblast-like synoviocytes. Cell. Immunol. 214:5459.
7. Balachandran, S.,, E. Thomas, and, G. N. Barber. 2004. A FADD-dependent innate immune mechanism in mammalian cells. Nature 432:401405.
8. Barnes, B. J.,, M. J. Kellum,, A. E. Field, and, P. M. Pitha. 2002. Multiple regulatory domains of IRF5 control activation, cellular localization, and induction of chemokines that mediate recruitment of T lymphocytes. Mol. Cell. Biol. 22:57215740.
9. Barnes, B. J.,, M. J. Kellum,, K. E. Pinder,, J. A. Frisancho, and, P. M. Pitha. 2003. Interferon regulatory factor 5, a novel mediator of cell cycle arrest and cell death. Cancer Res. 63:64246431.
10. Barnes, B. J.,, P. A. Moore, and, P. M. Pitha. 2001. Virus-specific activation of a novel interferon regulatory factor, IRF5, results in the induction of distinct interferon alpha genes. J. Biol. Chem. 276:2338223390.
11. Barnes, B. J.,, J. Richards,, M. Mancl,, S. Hanash,, L. Beretta, and, P. M. Pitha. 2004. Global and distinct targets of IRF5 and IRF7 during innate response to viral infection. J. Biol. Chem. 279:4519445207.
12. Barton, G. M.,, J. C. Kagan, and, R. Medzhitov. 2006. Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat. Immunol. 7:4956.
13. Boehm, J. S.,, J. J. Zhao,, J. Yao,, S. Y. Kim,, R. Firestein,, I. F. Dunn,, S. K. Sjostrom,, L. A. Garraway,, S. Weremowicz,, A. L. Richardson,, H. Greulich,, C. J. Stewart,, L. A. Mulvey,, R. R. Shen,, L. Ambrogio,, T. Hirozane-Kishikawa,, D. E. Hill,, M. Vidal,, M. Meyerson,, J. K. Grenier,, G. Hinkle,, D. E. Root,, T. M. Roberts,, E. S. Lander,, K. Polyak, and, W. C. Hahn. 2007. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 129:10651079.
14. Bonif, M.,, M. A. Meuwis,, P. Close,, V. Benoit,, K. Heyninck,, J. P. Chapelle,, V. Bours,, M. P. Merville,, J. Piette,, R. Beyaert, and, A. Chariot. 2006. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation. Biochem. J. 394:593603.
15. Bonnard, M.,, C. Mirtsos,, S. Suzuki,, K. Graham,, J. Huang,, M. Ng,, A. Itie,, A. Wakeham,, A. Shahinian,, W. J. Henzel,, A. J. Elia,, W. Shillinglaw,, T. W. Mak,, Z. Cao, and, W. C. Yeh. 2000. Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J. 19:49764985.
16. Boone, D. L.,, E. E. Turer,, E. G. Lee,, R. C. Ahmad,, M. T. Wheeler,, C. Tsui,, P. Hurley,, M. Chien,, S. Chai,, O. Hitotsumatsu,, E. McNally,, C. Pickart, and, A. Ma. 2004. The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat. Immunol. 5:10521060.
17. Bukau, B.,, E. Deuerling,, C. Pfund, and, E. A. Craig. 2000. Getting newly synthesized proteins into shape. Cell 101:119122.
18. Bustamante, J.,, S. Boisson-Dupuis,, E. Jouanguy,, C. Picard,, A. Puel,, L. Abel, and, J. L. Casanova. 2008. Novel primary immunodeficiencies revealed by the investigation of paediatric infectious diseases. Curr. Opin. Immunol. 20:3948.
19. Cadepond, F.,, G. Schweizer-Groyer,, I. Segard-Maurel,, N. Jibard,, S. M. Hollenberg,, V. Giguere,, R. M. Evans, and, E. E. Baulieu. 1991. Heat shock protein 90 as a critical factor in maintaining glucocorticosteroid receptor in a nonfunctional state. J. Biol. Chem. 266:58345841.
20. Carpenter, S., and, L. A. O’Neill. 2007. How important are Toll-like receptors for antimicrobial responses? Cell. Microbiol. 9:18911901.
21. Chariot, A.,, A. Leonardi,, J. Muller,, M. Bonif,, K. Brown, and, U. Siebenlist. 2002. Association of the adaptor TANK with the IkappaB kinase (IKK) regulator NEMO connects IKK complexes with IKK epsilon and TBK1 kinases. J. Biol. Chem. 277:3702937036.
22. Cheng, G., and, D. Baltimore. 1996. TANK, a co-inducer with TRAF2 of TNF- and CD 40L-mediated NF-kappaB activation. Genes Dev. 10:963973.
23. Cheng, T. F.,, S. Brzostek,, O. Ando,, S. Van Scoy,, K. P. Kumar, and, N. C. Reich. 2006. Differential activation of IFN regulatory factor (IRF)-3 and IRF5 transcription factors during viral infection. J. Immunol. 176:74627470.
24. Chien, Y.,, S. Kim,, R. Bumeister,, Y. M. Loo,, S. W. Kwon,, C. L. Johnson,, M. G. Balakireva,, Y. Romeo,, L. Kopelovich,, M. Gale, Jr.,, C. Yeaman,, J. H. Camonis,, Y. Zhao, and, M. A. White. 2006. RalB GTPase-mediated activation of the IkappaB family kinase TBK1 couples innate immune signaling to tumor cell survival. Cell 127:157170.
25. Civas, A.,, P. Genin,, P. Morin,, R. Lin, and, J. Hiscott. 2006. Promoter organization of the interferon-A genes differentially affects virus-induced expression and responsiveness to TBK1 and IKKepsilon. J. Biol. Chem. 281:48564866.
26. Colonna, M.,, G. Trinchieri, and, Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:12191226.
27. Courtois, G., and, A. Smahi. 2006. NF-kappaB-related genetic diseases. Cell Death Differ. 13:843851.
28. Diebold, S. S.,, T. Kaisho,, H. Hemmi,, S. Akira, and, C. Reis e Sousa. 2004. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303:15291531.
29. Elco, C. P.,, J. M. Guenther,, B. R. Williams, and, G. C. Sen. 2005. Analysis of genes induced by Sendai virus infection of mutant cell lines reveals essential roles of interferon regulatory factor 3, NF-kappaB, and interferon but not Toll-like receptor 3. J. Virol. 79:39203929.
30. Ely, K. R.,, R. Kodandapani, and, S. Wu. 2007. Protein-protein interactions in TRAF3. Adv. Exp. Med. Biol. 597:114121.
31. Evans, P. C.,, H. Ovaa,, M. Hamon,, P. J. Kilshaw,, S. Hamm,, S. Bauer,, H. L. Ploegh, and, T. S. Smith. 2004. Zinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activity. Biochem. J. 378:727734.
32. Feldman, D. E., and, J. Frydman. 2000. Protein folding in vivo: the importance of molecular chaperones. Curr. Opin. Struct. Biol. 10:2633.
33. Filipe-Santos, O.,, J. Bustamante,, M. H. Haverkamp,, E. Vinolo,, C. L. Ku,, A. Puel,, D. M. Frucht,, K. Christel,, H. von Bernuth,, E. Jouanguy,, J. Feinberg,, A. Durandy,, B. Senechal,, A. Chapgier,, G. Vogt,, L. de Beaucoudrey,, C. Fieschi,, C. Picard,, M. Garfa,, J. Chemli,, M. Bejaoui,, M. N. Tsolia,, N. Kutukculer,, A. Plebani,, L. Notarangelo,, C. Bodemer,, F. Geissmann,, A. Israel,, M. Veron,, M. Knackstedt,, R. Barbouche,, L. Abel,, K. Magdorf,, D. Gendrel,, F. Agou,, S. M. Holland, and, J. L. Casanova. 2006. X-linked susceptibility to mycobacteria is caused by mutations in NEMO impairing CD40-dependent IL-12 production. J. Exp. Med. 203:17451759.
34. Fitzgerald, K. A.,, S. M. McWhirter,, K. L. Faia,, D. C. Rowe,, E. Latz,, D. T. Golenbock,, A. J. Coyle,, S. M. Liao, and, T. Maniatis. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat. Immunol. 4:491496.
35. Fitzgerald, K. A.,, D. C. Rowe,, B. J. Barnes,, D. R. Caffrey,, A. Visintin,, E. Latz,, B. Monks,, P. M. Pitha, and, D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF3/7 and NF-kappaB involves the Toll adapters TRAM and TRIF. J. Exp. Med. 198:10431055.
36. Fontan, E.,, F. Traincard,, S. G. Levy,, S. Yamaoka,, M. Veron, and, F. Agou. 2007. NEMO oligomerization in the dynamic assembly of the IkappaB kinase core complex. FEBS J. 274:25402451.
37. Fujita, F.,, Y. Taniguchi,, T. Kato,, Y. Narita,, A. Furuya,, T. Ogawa,, H. Sakurai,, T. Joh,, M. Itoh,, M. Delhase,, M. Karin, and, M. Nakanishi. 2003. Identification of NAP1, a regulatory subunit of IkappaB kinase-related kinases that potentiates NF-kappaB signaling. Mol. Cell. Biol. 23:77807793.
38. Funami, K.,, M. Sasai,, Y. Ohba,, H. Oshiumi,, T. Seya, and, M. Matsumoto. 2007. Spatiotemporal mobilization of Toll/IL-1 receptor domain-containing adaptor molecule-1 in response to dsRNA. J. Immunol. 179:68676872.
39. Gatot, J. S.,, R. Gioia,, T. L. Chau,, F. Patrascu,, M. Warnier,, P. Close,, J. P. Chapelle,, E. Muraille,, K. Brown,, U. Siebenlist,, J. Piette,, E. Dejardin, and, A. Chariot. 2007. Lipopolysaccharide-mediated interferon regulatory factor activation involves TBK1-IKKepsilon-dependent Lys(63)-linked polyubiquitination and phosphorylation of TANK/I-TRAF. J. Biol. Chem. 282:3113131146.
40. Geiss, G.,, G. Jin,, J. Guo,, R. Bumgarner,, M. G. Katze, and, G. C. Sen. 2001. A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling. J. Biol. Chem. 276:3017830182.
41. Genin, P.,, M. Algarte,, P. Roof,, R. Lin, and, J. Hiscott. 2000. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappaB and IFN-regulatory factor transcription factors. J. Immunol. 164:53525361.
42. Giguere, V.,, S. M. Hollenberg,, M. G. Rosenfeld, and, R. M. Evans. 1986. Functional domains of the human glucocorticoid receptor. Cell 46:645652.
43. Gilmore, T. D. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene 25:66806684.
44. Gitlin, L.,, W. Barchet,, S. Gilfillan,, M. Cella,, B. Beutler,, R. A. Flavell,, M. S. Diamond, and, M. Colonna. 2006. Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. Proc. Natl. Acad. Sci. USA 103:84598464.
45. Grandvaux, N.,, M. J. Servant,, B. tenOever,, G. C. Sen,, S. Balachandran,, G. N. Barber,, R. Lin, and, J. Hiscott. 2002. Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes. J. Virol. 76:55325539.
46. Guo, B., and, G. Cheng. 2007. Modulation of the interferon antiviral response by the TBK1/IKKi adaptor protein TANK. J. Biol. Chem. 282:1181711826.
47. Hacker, H.,, V. Redecke,, B. Blagoev,, I. Kratchmarova,, L. C. Hsu,, G. G. Wang,, M. P. Kamps,, E. Raz,, H. Wagner,, G. Hacker,, M. Mann, and, M. Karin. 2006. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6. Nature 439:204207.
48. Hamad, N. M.,, J. H. Elconin,, A. E. Karnoub,, W. Bai,, J. N. Rich,, R. T. Abraham,, C. J. Der, and, C. M. Counter. 2002. Distinct requirements for Ras oncogenesis in human versus mouse cells. Genes. Dev. 16:20452057.
49. Harris, J.,, S. Oliere,, S. Sharma,, Q. Sun,, R. Lin,, J. Hiscott, and, N. Grandvaux. 2006. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK epsilon. J. Immunol. 177:25272535.
50. Hashimoto, C.,, K. L. Hudson, and, K. V. Anderson. 1988. The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein. Cell 52:269279.
51. Heil, F.,, H. Hemmi,, H. Hochrein,, F. Ampenberger,, C. Kirschning,, S. Akira,, G. Lipford,, H. Wagner, and, S. Bauer. 2004. Species-specific recognition of single-stranded RNA via Toll-like receptor 7 and 8. Science 303:15261529.
52. Hemmi, H.,, O. Takeuchi,, S. Sato,, M. Yamamoto,, T. Kaisho,, H. Sanjo,, T. Kawai,, K. Hoshino,, K. Takeda, and, S. Akira. 2004. The roles of two IkappaB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection. J. Exp. Med. 199:16411650.
53. Heyninck, K., and, R. Beyaert. 1999. The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett. 442:147150.
54. Hiscott, J. 2007. Convergence of the NF-kappaB and IRF pathways in the regulation of the innate antiviral response. Cytokine Growth Factor Rev. 18:483490.
55. Hiscott, J.,, D. Alper,, L. Cohen,, J. F. Leblanc,, L. Sportza,, A. Wong, and, S. Xanthoudakis. 1989. Induction of human interferon gene expression is associated with a nuclear factor that interacts with the NF-kappaB site of the human immunodeficiency virus enhancer. J. Virol. 63:25572566.
56. Hiscott, J.,, J. Lacoste, and, R. Lin. 2006. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3–4A protease. Biochem. Pharmacol. 72:14771484.
57. Hiscott, J.,, P. Pitha,, P. Genin,, H. Nguyen,, C. Heylbroeck,, Y. Mamane,, M. Algarte, and, R. Lin. 1999. Triggering the interferon response: the role of IRF3 transcription factor. J. Interferon Cytokine Res. 19:113.
58. Honda, K.,, A. Takaoka, and, T. Taniguchi. 2006. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 25:349360.
59. Honda, K., and, T. Taniguchi. 2006. IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nat. Rev. Immunol. 6:644658.
60. Honda, K.,, H. Yanai,, H. Negishi,, M. Asagiri,, M. Sato,, T. Mizutani,, N. Shimada,, Y. Ohba,, A. Takaoka,, N. Yoshida, and, T. Taniguchi. 2005. IRF7 is the master regulator of type-I interferon-dependent immune responses. Nature 434:772777.
61. Hornung, V.,, J. Ellegast,, S. Kim,, K. Brzozka,, A. Jung,, H. Kato,, H. Poeck,, S. Akira,, K. K. Conzelmann,, M. Schlee,, S. Endres, and, G. Hartmann. 2006. 5′-Triphosphate RNA is the ligand for RIG-I. Science 314:994997.
62. Huang, J.,, T. Liu,, L. G. Xu,, D. Chen,, Z. Zhai, and, H. B. Shu. 2005. SIKE is an IKK epsilon/TBK1-associated suppressor of TLR3- and virus-triggered IRF3 activation pathways. EMBO J. 24:40184028.
63. Ikeda, F.,, C. M. Hecker,, A. Rozenknop,, R. D. Nordmeier,, V. Rogov,, K. Hofmann,, S. Akira,, V. Dotsch, and, I. Dikic. 2007. Involvement of the ubiquitin-like domain of TBK1/IKK-i kinases in regulation of IFN-inducible genes. EMBO J. 26:34513462.
64. Ishii, K. J., and, S. Akira. 2006. Innate immune recognition of, and regulation by, DNA. Trends Immunol. 27:525532.
65. Izaguirre, A.,, B. J. Barnes,, S. Amrute,, W. S. Yeow,, N. Megjugorac,, J. Dai,, D. Feng,, E. Chung,, P. M. Pitha, and, P. Fitzgerald-Bocarsly. 2003. Comparative analysis of IRF and IFN-alpha expression in human plasmacytoid and monocyte-derived dendritic cells. J. Leukoc. Biol. 74:11251138.
66. Jakob, U.,, H. Lilie,, I. Meyer, and, J. Buchner. 1995. Transient interaction of Hsp90 with early unfolding intermediates of citrate synthase. Implications for heat shock in vivo. J. Biol. Chem. 270:72887294.
67. Juang, Y. T.,, W. Lowther,, M. Kellum,, W. C. Au,, R. Lin,, J. Hiscott, and, P. M. Pitha. 1998. Primary activation of interferon A and interferon B gene transcription by interferon regulatory factor 3. Proc. Natl. Acad. Sci. USA 95:98379842.
68. Karin, M. 2006. Nuclear factor-kappaB in cancer development and progression. Nature 441:431436.
69. Karin, M.,, T. Lawrence, and, V. Nizet. 2006. Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer. Cell 124:823835.
70. Kato, H.,, S. Sato,, M. Yoneyama,, M. Yamamoto,, S. Uematsu,, K. Matsui,, T. Tsujimura,, K. Takeda,, T. Fujita,, O. Takeuchi, and, S. Akira. 2005. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23:1928.
71. Kato, H.,, O. Takeuchi,, S. Sato,, M. Yoneyama,, M. Yamamoto,, K. Matsui,, S. Uematsu,, A. Jung,, T. Kawai,, K. J. Ishii,, O. Yamaguchi,, K. Otsu,, T. Tsujimura,, C. S. Koh,, C. Reis e Sousa,, Y. Matsuura,, T. Fujita, and, S. Akira. 2006. Differential roles of MDA-5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101105.
72. Kawai, T., and, S. Akira. 2006. Innate immune recognition of viral infection. Nat. Immunol. 7:131137.
73. Kawai, T., and, S. Akira. 2007. Signaling to NF-kappaB by Toll-like receptors. Trends Mol. Med. 13:460469.
74. Kawai, T.,, K. Takahashi,, S. Sato,, C. Coban,, H. Kumar,, H. Kato,, K. J. Ishii,, O. Takeuchi, and, S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and MDA-5-mediated type I interferon induction. Nat. Immunol. 6:981988.
75. Kayagaki, N.,, Q. Phung,, S. Chan,, R. Chaudhari,, C. Quan,, K. M. O’Rourke,, M. Eby,, E. Pietras,, G. Cheng,, J. F. Bazan,, Z. Zhang,, D. Arnott, and, V. M. Dixit. 2007. DUBA: a deubiquitinase that regulates type I interferon production. Science 318:16281632.
76. Kishore, N.,, Q. K. Huynh,, S. Mathialagan,, T. Hall,, S. Rouw,, D. Creely,, G. Lange,, J. Caroll,, B. Reitz,, A. Donnelly,, H. Boddupalli,, R. G. Combs,, K. Kretzmer, and, C. S. Tripp. 2002. IKK-i and TBK1 are enzymatically distinct from the homologous enzyme IKK-2: comparative analysis of recombinant human IKK-i, TBK1, and IKK-2. J. Biol. Chem. 277:1384013847.
77. Korherr, C.,, H. Gille,, R. Schafer,, K. Koenig-Hoffmann,, J. Dixelius,, K. A. Egland,, I. Pastan, and, U. Brinkmann. 2006. Identification of proangiogenic genes and pathways by high-throughput functional genomics: TBK1 and the IRF3 pathway. Proc. Natl. Acad. Sci. USA 103:42404245.
78. Kravchenko, V. V.,, J. C. Mathison,, K. Schwamborn,, F. Mercurio, and, R. J. Ulevitch. 2003. IKKi/IKKepsilon plays a key role in integrating signals induced by pro-inflammatory stimuli. J. Biol. Chem. 278:2661226619.
79. Krug, A.,, A. R. French,, W. Barchet,, J. A. Fischer,, A. Dzionek,, J. T. Pingel,, M. M. Orihuela,, S. Akira,, W. M. Yokoyama, and, M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21:107119.
80. Kumar, H.,, T. Kawai,, H. Kato,, S. Sato,, K. Takahashi,, C. Coban,, M. Yamamoto,, S. Uematsu,, K. J. Ishii,, O. Takeuchi, and, S. Akira. 2006. Essential role of IPS-1 in innate immune responses against RNA viruses. J. Exp. Med. 203:17951803.
81. Kumar, K. P.,, K. M. McBride,, B. K. Weaver,, C. Dingwall, and, N. C. Reich. 2000. Regulated nuclear-cytoplasmic localization of interferon regulatory factor 3, a subunit of double-stranded RNA-activated factor 1. Mol. Cell. Biol. 20:41594168.
82. Lallemand, C.,, B. Blanchard,, M. Palmieri,, P. Lebon,, E. May, and, M. G. Tovey. 2007. Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF3 and CREB. Oncogene 26:328338.
83. Lamothe, B.,, A. Besse,, A. D. Campos,, W. K. Webster,, H. Wu, and, B. G. Darnay. 2007. Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of IkappaB kinase activation. J. Biol. Chem. 282:41024112.
84. [Reference deleted.]
85. Latz, E.,, A. Verma,, A. Visintin,, M. Gong,, C. M. Sirois,, D. C. Klein,, B. G. Monks,, C. J. McKnight,, M. S. Lamphier,, W. P. Duprex,, T. Espevik, and, D. T. Golenbock. 2007. Ligand-induced conformational changes allosterically activate Toll-like receptor 9. Nat. Immunol. 8:772779. (Corrigendum, 8:1266.)
86. Lemaitre, B. 2004. The road to Toll. Nat. Rev. Immunol. 4:521527.
87. Lemaitre, B.,, E. Nicolas,, L. Michaut,, J. M. Reichhart, and, J. A. Hoffmann. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973983.
88. Lenardo, M. J.,, C. M. Fan,, T. Maniatis, and, D. Baltimore. 1989. The involvement of NF-kappaB in beta-interferon gene regulation reveals its role as widely inducible mediator of signal transduction. Cell 57:287294.
89. Lin, R.,, P. Genin,, Y. Mamane, and, J. Hiscott. 2000. Selective DNA binding and association with the CREB binding protein coactivator contribute to differential activation of alpha/beta interferon genes by interferon regulatory factors 3 and 7. Mol. Cell. Biol. 20:63426353.
90. Lin, R.,, J. Lacoste,, P. Nakhaei,, Q. Sun,, L. Yang,, S. Paz,, P. Wilkinson,, I. Julkunen,, D. Vitour,, E. Meurs, and, J. Hiscott. 2006. Dissociation of a MAVS/IPS-1/VISA/ Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3–4A proteolytic cleavage. J. Virol. 80:60726083.
91. Lin, R.,, Y. Mamane, and, J. Hiscott. 2000. Multiple regulatory domains control IRF7 activity in response to virus infection. J. Biol. Chem. 275:3432034327.
92. Lin, R.,, Y. Mamane, and, J. Hiscott. 1999. Structural and functional analysis of interferon regulatory factor 3: localization of the transactivation and autoinhibitory domains. Mol. Cell. Biol. 19:24652474.
93. Lin, R.,, L. Yang,, M. Arguello,, C. Penafuerte, and, J. Hiscott. 2005. A CRM1-dependent nuclear export pathway is involved in the regulation of IRF5 subcellular localization. J. Biol. Chem. 280:30883095.
94. Lin, R.,, L. Yang,, P. Nakhaei,, Q. Sun,, E. Sharif-Askari,, I. Julkunen, and, J. Hiscott. 2006. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 281:20952103.
95. Loo, Y. M.,, D. M. Owen,, K. Li,, A. K. Erickson,, C. L. Johnson,, P. M. Fish,, D. S. Carney,, T. Wang,, H. Ishida,, M. Yoneyama,, T. Fujita,, T. Saito,, W. M. Lee,, C. H. Hagedorn,, D. T. Lau,, S. A. Weinman,, S. M. Lemon, and, M. Gale, Jr. 2006. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection. Proc. Natl. Acad. Sci. USA 103:60016006.
96. Lu, R.,, W. C. Au,, W. S. Yeow,, N. Hageman, and, P. M. Pitha. 2000. Regulation of the promoter activity of interferon regulatory factor-7 gene. Activation by interferon and silencing by hypermethylation. J. Biol. Chem. 275:3180531812.
97. Lu, R.,, P. A. Moore, and, P. M. Pitha. 2002. Stimulation of IRF7 gene expression by tumor necrosis factor alpha: requirement for NF-kappaB transcription factor and gene accessibility. J. Biol. Chem. 277:1659216598.
98. Mamane, Y.,, C. Heylbroeck,, P. Genin,, M. Algarte,, M. J. Servant,, C. LePage,, C. DeLuca,, H. Kwon,, R. Lin, and, J. Hiscott. 1999. Interferon regulatory factors: the next generation. Gene 237:114.
99. Mancl, M. E.,, G. Hu,, N. Sangster-Guity,, S. L. Olshalsky,, K. Hoops,, P. Fitzgerald-Bocarsly,, P. M. Pitha,, K. Pinder, and, B. J. Barnes. 2005. Two discrete promoters regulate the alternatively spliced human interferon regulatory factor-5 isoforms. Multiple isoforms with distinct cell type-specific expression, localization, regulation, and function. J. Biol. Chem. 280:2107821090.
100. Marie, I.,, J. E. Durbin, and, D. E. Levy. 1998. Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7. EMBO J. 17:66606669.
101. Marie, I.,, E. Smith,, A. Prakash, and, D. E. Levy. 2000. Phosphorylation-induced dimerization of interferon regulatory factor 7 unmasks DNA binding and a bipartite transactivation domain. Mol. Cell. Biol. 20:88038814.
102. Matsui, K.,, Y. Kumagai,, H. Kato,, S. Sato,, T. Kawagoe,, S. Uematsu,, O. Takeuchi, and, S. Akira. 2006. Cutting edge: role of TANK-binding kinase 1 and inducible IkappaB kinase in IFN responses against viruses in innate immune cells. J. Immunol. 177:57855789.
103. McCoy, C. E., and, L. A. O’Neill. 2008. The role of Toll-like receptors in macrophages. Front. Biosci. 13:6270.
104. McWhirter, S. M.,, K. A. Fitzgerald,, J. Rosains,, D. C. Rowe,, D. T. Golenbock, and, T. Maniatis. 2004. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl. Acad. Sci. USA 101:233238.
105. Merika, M., and, D. Thanos. 2001. Enhanceosomes. Curr. Opin. Genet. Dev. 11:205208.
106. Meylan, E.,, J. Curran,, K. Hofmann,, D. Moradpour,, M. Binder,, R. Bartenschlager, and, J. Tschopp. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:11671172.
107. Morin, P.,, J. Braganca,, M. T. Bandu,, R. Lin,, J. Hiscott,, J. Doly, and, A. Civas. 2002. Preferential binding sites for interferon regulatory factors 3 and 7 involved in interferon-A gene transcription. J. Mol. Biol. 316:10091022.
108. Nabel, G., and, D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711713.
109. Nakaya, T.,, M. Sato,, N. Hata,, M. Asagiri,, H. Suemori,, S. Noguchi,, N. Tanaka, and, T. Taniguchi. 2001. Gene induction pathways mediated by distinct IRFs during viral infection. Biochem. Biophys. Res. Commun. 283:11501156.
110. Nelson, D. L. 2006. NEMO, NFκB signaling and incontinentia pigmenti. Curr. Opin. Genet. Dev. 16:282288.
111. Nomura, F.,, T. Kawai,, K. Nakanishi, and, S. Akira. 2000. NF-kappaB activation through IKK-i-dependent I-TRAF/TANK phosphorylation. Genes Cells. 5:191202.
112. O’Neill, L. A., and, A. G. Bowie. 2007. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat. Rev. Immunol. 7:353364.
113. Onomoto, K.,, M. Yoneyama, and, T. Fujita. 2007. Regulation of antiviral innate immune responses by RIG-I family of RNA helicases. Curr. Top. Microbiol. Immunol. 316:193205.
114. Osterlund, P. I.,, T. E. Pietila,, V. Veckman,, S. V. Kotenko, and, I. Julkunen. 2007. IFN regulatory factor family members differentially regulate the expression of type III IFN (IFN-lambda) genes. J. Immunol. 179:34343442.
115. Ozato, K.,, H. Tsujimura, and, T. Tamura. 2002. Toll-like receptor signaling and regulation of cytokine gene expression in the immune system. Biotechniques 2002(Suppl.):6668, 70, 72 passim.
116. Panne, D.,, T. Maniatis, and, S. C. Harrison. 2004. Crystal structure of ATF-2/c-Jun and IRF3 bound to the interferon-beta enhancer. EMBO J. 23:43844393.
117. Panne, D.,, S. M. McWhirter,, T. Maniatis, and, S. C. Harrison. 2007. Interferon regulatory factor 3 is regulated by a dual phosphorylation-dependent switch. J. Biol. Chem. 282:2281622822.
118. Paz, S.,, Q. Sun,, P. Nakhaei,, R. Romieu-Mourez,, D. Goubau,, I. Julkunen,, R. Lin, and, J. Hiscott. 2006. Induction of IRF3 and IRF7 phosphorylation following activation of the RIG-I pathway. Cell. Mol. Biol. (Noisy-le-grand) 52:1728.
119. Pernis, A. B. 2002. The role of IRF-4 in B and T cell activation and differentiation. J. Interferon Cytokine Res. 22:111120.
120. Perry, A. K.,, E. K. Chow,, J. B. Goodnough,, W. C. Yeh, and, G. Cheng. 2004. Differential requirement for TANK-binding kinase-1 in type I interferon responses to Toll-like receptor activation and viral infection. J. Exp. Med. 199:16511658.
121. Peters, R. T.,, S. M. Liao, and, T. Maniatis. 2000. IKKepsilon is part of a novel PMA-inducible IkappaB kinase complex. Mol. Cell 5:513522.
122. Peters, R. T., and, T. Maniatis. 2001. A new family of IKK-related kinases may function as IkappaB kinase kinases. Biochim. Biophys. Acta 1471:M57M62.
123. Pichlmair, A.,, O. Schulz,, C. P. Tan,, T. I. Naslund,, P. Liljestrom,, F. Weber, and, C. Reis e Sousa. 2006. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5′-phosphates. Science 314:9971001.
124. Pomerantz, J. L., and, D. Baltimore. 1999. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKK-related kinase. EMBO J. 18:66946704.
125. Puel, A.,, C. Picard,, C. L. Ku,, A. Smahi, and, J. L. Casanova. 2004. Inherited disorders of NF-kappaB-mediated immunity in man. Curr. Opin. Immunol. 16:3441.
126. Qin, B. Y.,, C. Liu,, S. S. Lam,, H. Srinath,, R. Delston,, J. J. Correia,, R. Derynck, and, K. Lin. 2003. Crystal structure of IRF3 reveals mechanism of autoinhibition and virus-induced phosphoactivation. Nat. Struct. Biol. 10:913921.
127. Qin, B. Y.,, C. Liu,, H. Srinath,, S. S. Lam,, J. J. Correia,, R. Derynck, and, K. Lin. 2005. Crystal structure of IRF3 in complex with CBP. Structure (Camb.) 13:12691277.
128. Qing, J.,, C. Liu,, L. Choy,, R. Y. Wu,, J. S. Pagano, and, R. Derynck. 2004. Transforming growth factor beta/Smad3 signaling regulates IRF7 function and transcriptional activation of the beta interferon promoter. Mol. Cell. Biol. 24:14111425.
129. Radons, J.,, S. Dove,, D. Neumann,, R. Altmann,, A. Botzki,, M. U. Martin, and, W. Falk. 2003. The interleukin 1 (IL-1) receptor accessory protein Toll/IL-1 receptor domain: analysis of putative interaction sites by in vitro mutagenesis and molecular modeling. J. Biol. Chem. 278:4914549153.
130. Radons, J.,, S. Gabler,, H. Wesche,, C. Korherr,, R. Hofmeister, and, W. Falk. 2002. Identification of essential regions in the cytoplasmic tail of interleukin-1 receptor accessory protein critical for interleukin-1 signaling. J. Biol. Chem. 277:1645616463.
131. Rangarajan, A.,, S. J. Hong,, A. Gifford, and, R. A. Weinberg. 2004. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 6:171183.
132. Roach, J. C.,, G. Glusman,, L. Rowen,, A. Kaur,, M. K. Purcell,, K. D. Smith,, L. E. Hood, and, A. Aderem. 2005. The evolution of vertebrate Toll-like receptors. Proc. Natl. Acad. Sci. USA 102:95779582.
133. Romieu-Mourez, R.,, E. Landesman-Bollag,, D. C. Seldin, and, G. E. Sonenshein. 2002. Protein kinase CK2 promotes aberrant activation of nuclear factor-kappaB, transformed phenotype, and survival of breast cancer cells. Cancer Res. 62:67706778.
134. Romieu-Mourez, R.,, E. Landesman-Bollag,, D. C. Seldin,, A. M. Traish,, F. Mercurio, and, G. E. Sonenshein. 2001. Roles of IKK kinases and protein kinase CK2 in activation of nuclear factor-kappaB in breast cancer. Cancer Res. 61:38103818.
135. Romieu-Mourez, R.,, M. Solis,, A. Nardin,, D. Goubau,, V. Baron-Bodo,, R. Lin,, B. Massie,, M. Salcedo, and, J. Hiscott. 2006. Distinct roles for IFN regulatory factor (IRF)-3 and IRF7 in the activation of antitumor properties of human macrophages. Cancer Res. 66:1057610585.
136. Rothe, M.,, J. Xiong,, H. B. Shu,, K. Williamson,, A. Goddard, and, D. V. Goeddel. 1996. I-TRAF is a novel TRAF-interacting protein that regulates TRAF-mediated signal transduction. Proc. Natl. Acad. Sci. USA 93:82418246.
137. Ryzhakov, G., and, F. Randow. 2007. SINTBAD, a novel component of innate antiviral immunity, shares a TBK1-binding domain with NAP1 and TANK. EMBO J. 26:31803190.
138. Saha, S. K.,, E. M. Pietras,, J. Q. He,, J. R. Kang,, S. Y. Liu,, G. Oganesyan,, A. Shahangian,, B. Zarnegar,, T. L. Shiba,, Y. Wang, and, G. Cheng. 2006. Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J. 25:32573263.
139. Saito, T.,, R. Hirai,, Y. M. Loo,, D. Owen,, C. L. Johnson,, S. C. Sinha,, S. Akira,, T. Fujita, and, M. Gale, Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc. Natl. Acad. Sci. USA 104:582587.
140. Saitoh, T.,, M. Yamamoto,, M. Miyagishi,, K. Taira,, M. Nakanishi,, T. Fujita,, S. Akira,, N. Yamamoto, and, S. Yamaoka. 2005. A20 is a negative regulator of IFN regulatory factor 3 signaling. J. Immunol. 174:15071512.
141. Sasai, M.,, H. Oshiumi,, M. Matsumoto,, N. Inoue,, F. Fujita,, M. Nakanishi, and, T. Seya. 2005. Cutting edge: NF-kappaB-activating kinase-associated protein 1 participates in TLR3/Toll-IL-1 homology domain-containing adapter molecule-1-mediated IFN regulatory factor 3 activation. J. Immunol. 174:2730.
142. Sasai, M.,, M. Shingai,, K. Funami,, M. Yoneyama,, T. Fujita,, M. Matsumoto, and, T. Seya. 2006. NAK-associated protein 1 participates in both the TLR3 and the cytoplasmic pathways in type I IFN induction. J. Immunol. 177:86768683.
143. Sato, M.,, N. Hata,, M. Asagiri,, T. Nakaya,, T. Taniguchi, and, N. Tanaka. 1998. Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF7. FEBS Lett. 441:106110.
144. Sato, M.,, H. Suemori,, N. Hata,, M. Asagiri,, K. Ogasawara,, K. Nakao,, T. Nakaya,, M. Katsuki,, S. Noguchi,, N. Tanaka, and, T. Taniguchi. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539548.
145. Schoenemeyer, A.,, B. J. Barnes,, M. E. Mancl,, E. Latz,, N. Goutagny,, P. M. Pitha,, K. A. Fitzgerald, and, D. T. Golenbock. 2005. The interferon regulatory factor, IRF5, is a central mediator of Toll-like receptor 7 signaling. J. Biol. Chem. 280:1700517012.
146. Sebban-Benin, H.,, A. Pescatore,, F. Fusco,, V. Pascuale,, J. Gautheron,, S. Yamaoka,, A. Moncla,, M. V. Ursini, and, G. Courtois. 2007. Identification of TRAF6-dependent NEMO polyubiquitination sites through analysis of a new NEMO mutation causing incontinentia pigmenti. Hum. Mol. Genet. 16:28052815.
147. Sen, R., and, D. Baltimore. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein NF-kappaB by a posttranslational mechanism. Cell 47:921928.
148. Sen, R., and, D. Baltimore. 1986. Multiple nuclear factors interact with the immunoglobulin enhancer sequences. Cell 46:705716.
149. Servant, M. J.,, N. Grandvaux,, B. R. tenOever,, D. Duguay,, R. Lin, and, J. Hiscott. 2003. Identification of the minimal phosphoacceptor site required for in vivo activation of interferon regulatory factor 3 in response to virus and double-stranded RNA. J. Biol. Chem. 278:94419447.
150. Seth, R. B.,, L. Sun,, C. K. Ea, and, Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122:669682.
151. Sharma, S.,, B. R. tenOever,, N. Grandvaux,, G. P. Zhou,, R. Lin, and, J. Hiscott. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:11481151.
152. Shimada, T.,, T. Kawai,, K. Takeda,, M. Matsumoto,, J. Inoue,, Y. Tatsumi,, A. Kanamaru, and, S. Akira. 1999. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int. Immunol. 11:13571362.
153. Sun, Q.,, L. Sun,, H. H. Liu,, X. Chen,, R. B. Seth,, J. Forman, and, Z. J. Chen. 2006. The specific and essential role of MAVS in antiviral innate immune responses. Immunity 24:633642.
154. Takahasi, K.,, N. N. Suzuki,, M. Horiuchi,, M. Mori,, W. Suhara,, Y. Okabe,, Y. Fukuhara,, H. Terasawa,, S. Akira,, T. Fujita, and, F. Inagaki. 2003. X-ray crystal structure of IRF3 and its functional implications. Nat. Struct. Biol. 10:922927.
155. Takaoka, A.,, H. Yanai,, S. Kondo,, G. Duncan,, H. Negishi,, T. Mizutani,, S. Kano,, K. Honda,, Y. Ohba,, T. W. Mak, and, T. Taniguchi. 2005. Integral role of IRF5 in the gene induction programme activated by Toll-like receptors. Nature 434:243249.
156. Tegethoff, S.,, J. Behlke, and, C. Scheidereit. 2003. Tetrameric oligomerization of IkappaB kinase gamma (IKKgamma) is obligatory for IKK complex activity and NF-kappaB activation. Mol. Cell. Biol. 23:20292041.
157. tenOever, B. R.,, S. L. Ng,, M. A. Chua,, S. M. McWhirter,, A. Garcia-Sastre, and, T. Maniatis. 2007. Multiple functions of the IKK-related kinase IKKepsilon in interferon-mediated antiviral immunity. Science 315:12741278.
158. tenOever, B. R.,, S. Sharma,, W. Zou,, Q. Sun,, N. Grandvaux,, I. Julkunen,, H. Hemmi,, M. Yamamoto,, S. Akira,, W. C. Yeh,, R. Lin, and, J. Hiscott. 2004. Activation of TBK1 and IKKepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity. J. Virol. 78:1063610649.
159. Tojima, Y.,, A. Fujimoto,, M. Delhase,, Y. Chen,, S. Hatakeyama,, K. Nakayama,, Y. Kaneko,, Y. Nimura,, N. Motoyama,, K. Ikeda,, M. Karin, and, M. Nakanishi. 2000. NAK is an IkappaB kinase-activating kinase. Nature 404:778782.
160. Uematsu, S., and, S. Akira. 2007. Toll-like receptors and type I interferons. J. Biol. Chem. 282:1531915323.
161. Uematsu, S.,, S. Sato,, M. Yamamoto,, T. Hirotani,, H. Kato,, F. Takeshita,, M. Matsuda,, C. Coban,, K. J. Ishii,, T. Kawai,, O. Takeuchi, and, S. Akira. 2005. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-α induction. J. Exp. Med. 201:915923.
162. Uzel, G. 2005. The range of defects associated with nuclear factor kappaB essential modulator. Curr. Opin. Allergy Clin. Immunol. 5:513518.
163. van Boxel-Dezaire, A. H.,, M. R. Rani, and, G. R. Stark. 2006. Complex modulation of cell type-specific signaling in response to type I interferons. Immunity 25:361372.
164. Visvanathan, K. V., and, S. Goodbourn. 1989. Double-stranded RNA activates binding of NF-kappa B to an inducible element in the human beta-interferon promoter. EMBO J. 8:11291138.
165. Wang, Y. Y.,, L. Li,, K. J. Han,, Z. Zhai, and, H. B. Shu. 2004. A20 is a potent inhibitor of TLR3- and Sendai virus-induced activation of NF-kappaB and ISRE and IFN-beta promoter. FEBS Lett. 576:8690.
166. Wertz, I. E.,, K. M. O’Rourke,, H. Zhou,, M. Eby,, L. Aravind,, S. Seshagiri,, P. Wu,, C. Wiesmann,, R. Baker,, D. L. Boone,, A. Ma,, E. V. Koonin, and, V. M. Dixit. 2004. De-ubiquitination and ubiquitin ligase domains of A20 downregulate NF-kappaB signalling. Nature 430:694699.
167. Wu, Z. H.,, Y. Shi,, R. S. Tibbetts, and, S. Miyamoto. 2006. Molecular linkage between the kinase ATM and NF-kappaB signaling in response to genotoxic stimuli. Science 311:11411146.
168. Xu, L. G.,, Y. Y. Wang,, K. J. Han,, L. Y. Li,, Z. Zhai, and, H. B. Shu. 2005. VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol. Cell 19:727740.
169. Xu, W.,, F. Yu,, M. Yan,, L. Lu,, W. Zou,, L. Sun,, Z. Zheng, and, X. Liu. 2004. Geldanamycin, a heat shock protein 90-binding agent, disrupts Stat5 activation in IL-2-stimulated cells. J. Cell. Physiol. 198:188196.
170. Xu, Y.,, X. Tao,, B. Shen,, T. Horng,, R. Medzhitov,, J. L. Manley, and, L. Tong. 2000. Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408:111115.
171. Yanai, H.,, H. M. Chen,, T. Inuzuka,, S. Kondo,, T. W. Mak,, A. Takaoka,, K. Honda, and, T. Taniguchi. 2007. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression. Proc. Natl. Acad. Sci. USA 104:34023407.
172. Yang, H.,, C. H. Lin,, G. Ma,, M. O. Baffi, and, M. G. Wathelet. 2003. Interferon regulatory factor-7 synergizes with other transcription factors through multiple interactions with p300/CBP coactivators. J. Biol. Chem. 278:1549515504.
173. Yang, H.,, G. Ma,, C. H. Lin,, M. Orr, and, M. G. Wathelet. 2004. Mechanism for transcriptional synergy between interferon regulatory factor (IRF)-3 and IRF-7 in activation of the interferon-beta gene promoter. Eur. J. Biochem. 271:36933703.
174. Yang, K.,, H. Shi,, R. Qi,, S. Sun,, Y. Tang,, B. Zhang, and, C. Wang. 2006. Hsp90 regulates activation of interferon regulatory factor 3 and TBK1 stabilization in Sendai virus-infected cells. Mol. Biol. Cell. 17:14611471.
175. Yoneyama, M.,, M. Kikuchi,, T. Natsukawa,, N. Shinobu,, T. Imaizumi,, M. Miyagishi,, K. Taira,, S. Akira, and, T. Fujita. 2004. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat. Immunol. 5:730737.
176. Zhang, L., and, J. S. Pagano. 2000. Interferon regulatory factor 7 is induced by Epstein-Barr virus latent membrane protein 1. J. Virol. 74:10611068.
177. Zhang, L., and, J. S. Pagano. 1997. IRF7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell. Biol. 17:57485757.
178. Zhao, T.,, L. Yang,, Q. Sun,, M. Arguello,, D. W. Ballard,, J. Hiscott, and, R. Lin. 2007. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat. Immunol. 8:592600.
179. Zou, J.,, Y. Guo,, T. Guettouche,, D. F. Smith, and, R. Voellmy. 1998. Repression of heat shock transcription factor HSF1 activation by HSP90 (HSP90 complex) that forms a stress-sensitive complex with HSF1. Cell 94:471480.

Tables

Generic image for table
Table 1

Biological properties of IRF proteins

Citation: Arguello M, Paz S, Hiscott J. 2009. Interferon Regulatory Factors and the Atypical IKK-Related Kinases TBK1 and IKK-ε: Essential Players in the Innate Immune Response to RNA Virus Infection, p 51-74. In Brasier A, García-Sastre A, Lemon S (ed), Cellular Signaling and Innate Immune Responses to RNA Virus Infections. ASM Press, Washington, DC. doi: 10.1128/9781555815561.ch5

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error